v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net loss $ (50,243) $ (39,636)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 3,570 4,151
Bargain purchase gain, net of tax (1,706)
Gain on disposal of fixed assets (15)
Impairment of intangible assets 3,027
Impairment of operating lease right-of-use assets 393
Impairment of property and equipment 12
Inventory write-downs 48 56
Share-based compensation expense 7,096 6,815
Net accretion of premium on short-term investments (535) (695)
Change in:    
Accounts receivable (1,021) (821)
Inventory (410) 69
Other current and non-current assets 1,818 (31)
Accounts payable (850) 246
Accrued liabilities 254 4,138
Contract liabilities and other current liabilities (765) (1,692)
Operating lease liabilities (1,299) (1,096)
Other long-term liabilities (476) 81
Net cash used in operating activities (39,393) (30,124)
Cash flows from investing activities    
Sales of investment securities 22,655 48,700
Purchases of investment securities (23,488) (17,302)
Cash paid for Ibeo business combination (6,300) (11,233)
Purchases of property and equipment (280) (1,484)
Net cash (used in) provided by investing activities (7,413) 18,681
Cash flows from financing activities    
Principal payments under finance leases (13)
Proceeds from stock option exercises 62 168
Net proceeds from issuance of common stock 26,109 55,866
Net cash provided by financing activities 26,171 56,021
Effect of exchange rate changes on cash and cash equivalents and restricted cash 26
Change in cash, cash equivalents, and restricted cash (20,609) 44,578
Cash, cash equivalents, and restricted cash at beginning of period 49,391 21,954
Cash, cash equivalents, and restricted cash at end of period 28,782 66,532
Supplemental schedule of non-cash investing and financing activities    
Non-cash additions to property and equipment 167
Amounts issued to escrow for acquisition consideration 3,263
Accrued financing fees 10 180
Issuance of common stock for subscriptions receivable 925
Foreign currency translation adjustments (64) 24
Unrealized (loss) gain on investment securities, available-for-sale $ (45) $ 95

Source